These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9667559)

  • 1. Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.
    Molyneux PD; Tofts PS; Fletcher A; Gunn B; Robinson P; Gallagher H; Moseley IF; Barker GJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):42-7. PubMed ID: 9667559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.
    Grimaud J; Lai M; Thorpe J; Adeleine P; Wang L; Barker GJ; Plummer DL; Tofts PS; McDonald WI; Miller DH
    Magn Reson Imaging; 1996; 14(5):495-505. PubMed ID: 8843362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique.
    Rovaris M; Gawne-Cain ML; Wang L; Miller DH
    Neuroradiology; 1997 Mar; 39(3):161-5. PubMed ID: 9106285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
    Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
    J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis.
    Gallagher HL; MacManus DG; Webb SL; Miller DH
    J Magn Reson Imaging; 1997; 7(2):439-41. PubMed ID: 9090605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain MRI lesion load quantification in multiple sclerosis: a comparison between automated multispectral and semi-automated thresholding computer-assisted techniques.
    Achiron A; Gicquel S; Miron S; Faibel M
    Magn Reson Imaging; 2002 Dec; 20(10):713-20. PubMed ID: 12591567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
    Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
    Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
    Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-automated thresholding technique for measuring lesion volumes in multiple sclerosis: effects of the change of the threshold on the computed lesion loads.
    Filippi M; Rovaris M; Campi A; Pereira C; Comi G
    Acta Neurol Scand; 1996 Jan; 93(1):30-4. PubMed ID: 8825269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized method of lesion volume quantitation in multiple sclerosis: error of serial studies.
    Simon JH; Scherzinger A; Raff U; Li X
    AJNR Am J Neuroradiol; 1997 Mar; 18(3):580-2. PubMed ID: 9090427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility.
    Guttmann CR; Kikinis R; Anderson MC; Jakab M; Warfield SK; Killiany RJ; Weiner HL; Jolesz FA
    J Magn Reson Imaging; 1999 Apr; 9(4):509-18. PubMed ID: 10232508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
    Horsfield MA; Rocca MA; Pagani E; Storelli L; Preziosa P; Messina R; Camesasca F; Copetti M; Filippi M
    J Neuroimaging; 2016 Jul; 26(4):395-402. PubMed ID: 27019077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques.
    Filippi M; Horsfield MA; Bressi S; Martinelli V; Baratti C; Reganati P; Campi A; Miller DH; Comi G
    Brain; 1995 Dec; 118 ( Pt 6)():1593-600. PubMed ID: 8595488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
    Lin X; Tench CR; Turner B; Blumhardt LD; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1090-4. PubMed ID: 12876240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study.
    Wicks DA; Tofts PS; Miller DH; du Boulay GH; Feinstein A; Sacares RP; Harvey I; Brenner R; McDonald WI
    Neuroradiology; 1992; 34(6):475-9. PubMed ID: 1436453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
    Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA
    Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure.
    Stone LA; Frank JA; Albert PS; Bash CN; Calabresi PA; Maloni H; McFarland HF
    Neurology; 1997 Sep; 49(3):862-9. PubMed ID: 9305355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b.
    Richert ND; Zierak MC; Bash CN; Lewis BK; McFarland HF; Frank JA
    Mult Scler; 2000 Apr; 6(2):86-90. PubMed ID: 10773853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes.
    Mitchell JR; Karlik SJ; Lee DH; Eliasziw M; Rice GP; Fenster A
    Med Phys; 1996 Jan; 23(1):85-97. PubMed ID: 8700036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.